rs139264192

Variant summary

Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2

The NM_015080.4(NRXN2):ā€‹c.3213C>Gā€‹(p.Leu1071Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00257 in 1,614,202 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…).

Frequency

Genomes: š‘“ 0.0020 ( 0 hom., cov: 32)
Exomes š‘“: 0.0026 ( 12 hom. )

Consequence

NRXN2
NM_015080.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: 0.711
Variant links:
Genes affected
NRXN2 (HGNC:8009): (neurexin 2) This gene encodes a member of the neurexin gene family. The products of these genes function as cell adhesion molecules and receptors in the vertebrate nervous system. These genes utilize two promoters. The majority of transcripts are produced from the upstream promoter and encode alpha-neurexin isoforms while a smaller number of transcripts are produced from the downstream promoter and encode beta-neuresin isoforms. The alpha-neurexins contain epidermal growth factor-like (EGF-like) sequences and laminin G domains, and have been shown to interact with neurexophilins. The beta-neurexins lack EGF-like sequences and contain fewer laminin G domains than alpha-neurexins. Alternative splicing and the use of alternative promoters may generate thousands of transcript variants (PMID: 12036300, PMID: 11944992).[provided by RefSeq, Jun 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -11 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 11-64648804-G-C is Benign according to our data. Variant chr11-64648804-G-C is described in ClinVar as [Benign]. Clinvar id is 211705.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr11-64648804-G-C is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.711 with no splicing effect.
BS2
High AC in GnomAd4 at 301 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NRXN2NM_015080.4 linkuse as main transcriptc.3213C>G p.Leu1071Leu synonymous_variant 16/23 ENST00000265459.11 NP_055895.1 Q9P2S2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NRXN2ENST00000265459.11 linkuse as main transcriptc.3213C>G p.Leu1071Leu synonymous_variant 16/235 NM_015080.4 ENSP00000265459.5 Q9P2S2-1
NRXN2ENST00000704782.1 linkuse as main transcriptc.3222C>G p.Leu1074Leu synonymous_variant 15/22 ENSP00000516031.1 A0A994J5C3
NRXN2ENST00000704781.1 linkuse as main transcriptc.3222C>G p.Leu1074Leu synonymous_variant 15/22 ENSP00000516029.1 A0A994J4N8

Frequencies

GnomAD3 genomes
AF:
0.00198
AC:
301
AN:
152200
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000265
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.00268
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00115
Gnomad SAS
AF:
0.000827
Gnomad FIN
AF:
0.00254
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00297
Gnomad OTH
AF:
0.00144
GnomAD3 exomes
AF:
0.00231
AC:
582
AN:
251458
Hom.:
2
AF XY:
0.00233
AC XY:
317
AN XY:
135912
show subpopulations
Gnomad AFR exome
AF:
0.000431
Gnomad AMR exome
AF:
0.000896
Gnomad ASJ exome
AF:
0.00109
Gnomad EAS exome
AF:
0.000272
Gnomad SAS exome
AF:
0.00248
Gnomad FIN exome
AF:
0.00333
Gnomad NFE exome
AF:
0.00324
Gnomad OTH exome
AF:
0.00179
GnomAD4 exome
AF:
0.00263
AC:
3846
AN:
1461884
Hom.:
12
Cov.:
32
AF XY:
0.00254
AC XY:
1849
AN XY:
727244
show subpopulations
Gnomad4 AFR exome
AF:
0.000418
Gnomad4 AMR exome
AF:
0.000827
Gnomad4 ASJ exome
AF:
0.000842
Gnomad4 EAS exome
AF:
0.000756
Gnomad4 SAS exome
AF:
0.00265
Gnomad4 FIN exome
AF:
0.00352
Gnomad4 NFE exome
AF:
0.00287
Gnomad4 OTH exome
AF:
0.00222
GnomAD4 genome
AF:
0.00198
AC:
301
AN:
152318
Hom.:
0
Cov.:
32
AF XY:
0.00185
AC XY:
138
AN XY:
74488
show subpopulations
Gnomad4 AFR
AF:
0.000265
Gnomad4 AMR
AF:
0.00268
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.00116
Gnomad4 SAS
AF:
0.000828
Gnomad4 FIN
AF:
0.00254
Gnomad4 NFE
AF:
0.00297
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.00250
Hom.:
0
Bravo
AF:
0.00182
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00229
EpiControl
AF:
0.00172

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoNov 13, 2015- -
NRXN2-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesNov 16, 2019This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
11
DANN
Benign
0.81

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139264192; hg19: chr11-64416276; API